Skip to main content

SG 461 Pill - blue oval, 13mm

Pill with imprint SG 461 is Blue, Oval and has been identified as Carbidopa and Levodopa Extended-Release 50 mg / 200 mg. It is supplied by ScieGen Pharmaceuticals Inc.

Carbidopa/levodopa is used in the treatment of Parkinson's Disease; Neuroleptic Malignant Syndrome; GTP-CH Deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 50 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for SG 461

Carbidopa and levodopa extended-release 50 mg / 200 mg SG 461

Carbidopa and Levodopa Extended-Release

Imprint
SG 461
Strength
50 mg / 200 mg
Color
Blue
Size
13.00 mm
Shape
Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
ScieGen Pharmaceuticals Inc.
National Drug Code (NDC)
50228-0461

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.